Please login to the form below

Not currently logged in
Email:
Password:

Europe misses flu vaccine target for at-risk groups

Netherlands only country where coverage is at recommended level, says WHO

The majority of countries in Europe are lagging far behind the recommended uptake for influenza vaccine in at-risk groups.

According to the World Health Organization (WHO), of the countries where data was available only the Netherlands managed to ensure more than 75 per cent of its elderly population had adequate flu protection.

Countries almost at the 75 per cent target included the UK, Spain, Italy and Belgium, but right at the other end of the scale were Poland, Lithuania and Estonia, all of which had less than 20 per cent coverage.

This is despite a very real problem regarding influenza in the elderly, with 90 per cent of deaths related to seasonal influenza estimated to occur among those aged over 65. Flu is also likely to be more severe in older people and this population takes longer to recover.

In addition to its guidance for the elderly, the WHO also recommends pregnant women, people with chronic medical conditions, residents of institutions for disabled people, healthcare workers and small children should be offered the seasonal influenza vaccine.

However, national recommendations for these groups vary widely, and data is far more limited than in the elderly where 94 per cent of European countries have set levels to aim for.

This lack of national recommendations is a contributing factor to the low uptake, according to the WHO, along with lack of knowledge and poor access for some groups to the vaccine.

To overcome this, the WHO wants national vaccine recommendations to be reviewed and potentially include pregnant woman and a cost-benefit assessment of flu vaccination programmes carried out to highlight its economic positives.

The WHO said risk groups should be prioritised in locations with limited access to vaccines, but acknowledged it needs to work with member states to improve public perception of the flu vaccine.

22nd October 2012

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Group

GEM Group a leading healthcare professional media buyer based in the UK working for clients across the globe....

Latest intelligence

How do you solve a problem like non-adherence? Part 2
Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment...
The patient will see you now
GCI Health’s Laura Starr and Chris Bath report on how the dawning era of mobile tech and the ‘Internet of Things’ has transformed the health and wellness arena....
When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast...

Infographics